Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
A Pisoni
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
S Marie
3Montpellier University Hospital, Montpellier, France.
C Soraya
3Montpellier University Hospital, Montpellier, France.
C Niels
3Montpellier University Hospital, Montpellier, France.
N Pansu
3Montpellier University Hospital, Montpellier, France.
D Morquin
3Montpellier University Hospital, Montpellier, France.
V Foulongne
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
A Bourdin
3Montpellier University Hospital, Montpellier, France.
V Le Moing
3Montpellier University Hospital, Montpellier, France.
P Van de Perre
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
Data Availability
Not available
Posted May 08, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (682)
- Anesthesia (182)
- Cardiovascular Medicine (2720)
- Dermatology (233)
- Emergency Medicine (410)
- Epidemiology (12366)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4215)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2723)
- Health Policy (1012)
- Hematology (369)
- HIV/AIDS (872)
- Medical Education (403)
- Medical Ethics (111)
- Nephrology (449)
- Neurology (3998)
- Nursing (216)
- Nutrition (592)
- Oncology (2106)
- Ophthalmology (600)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1142)
- Primary Care Research (464)
- Public and Global Health (6622)
- Radiology and Imaging (1438)
- Respiratory Medicine (881)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (171)